Value-added medicines hub
Value-added medicines are enhanced versions of existing medications, designed to improve patient outcomes and offer treatment options that could lead to better adherence.1
At Colonis, we support unseen and forgotten patient groups. By providing treatment options for those not having their needs met with current treatments, we improve ease of administration. This can mean better adherence,2 as patients have a choice to continue their treatment.
Explore our work and discover how we’re shaping the future of value-added medicines.
References: 1. Medicines for Europe. What is a value added medicine? Available from: https://www.medicinesforeurope.com/value-added-medicines/did-you-know/ [Accessed August 2026]. 2. Batchelor HK and Marriot JF. Br J Clin Pharmacol. 2013;79:405–418.
Top story
Opportunities and challenges in the future of value-added medicines
In this article we explore the opportunities that value-added medicines bring for patients and healthcare systems, along with challenges that still remain.
Latest insights
Explore our latest thought leadership pieces and infographics for up-to-date insights into the industry and the development of value-added medicines.
The cost of creating new medicines
How do the benefits of new medicines compare to those of value-added medicines (VAMs)? Our latest article discusses a recent study exploring the differences between the two.
Opportunities across the landscape of value-added medicines
At Colonis, we believe that innovation in value-added medicines (VAMs) is key for optimising patient outcomes. Our latest infographic explores the current landscape of VAMs, reviews the benefits to healthcare systems and patients, and considers the delivery framework needed to help transform the future of healthcare.
Navigating regulatory approval for value-added medicines
In terms of regulatory processes and considerations, value-added medicines fall in-between generics and new chemical entities. Here, we explore the differences in regulatory pathways for value-added medicines and how they contrast with other forms of medicine.
Innovation in value-added medicines
As the healthcare landscape continually evolves, value-added medicines are transforming patient care by taking medicines that already exist and creating innovative solutions that address patient needs. These innovations often lead to better patient outcomes and more convenient treatment options.
Evolution in the pharmaceutical industry
The world of pharma constantly strives for innovative ways to support patients – it’s part of the very fabric of the industry. Sometimes this involves creating something brand new, but it can also mean working with what already exists and improving it.
Case studies
Keep your eyes peeled for our upcoming case studies in this section. We’ll be sharing some real-life examples of the work we do and the impact it’s had on patients and HCPs.
Explore real-world stories about how we’re bringing value-added medicines to market, and changing the landscape of pharma to address unmet clinical needs in healthcare.
Product development at Colonis: developing value-added medicines for improved patient outcomes
At Colonis Pharma Ltd, we are dedicated to developing treatment options that help improve clinical care and enhance the patient experience. How do we achieve this? Through our streamlined product development process. This process is generally much faster than the traditional drug development route, which involves patient recruitment and clinical trials.